Review
Copyright ©The Author(s) 2015.
World J Neurol. Sep 28, 2015; 5(3): 88-101
Published online Sep 28, 2015. doi: 10.5316/wjn.v5.i3.88
Figure 1
Figure 1 Genetic mutations pathways implicated in the development of malignant gliomas (76). WHO: World Health Organization; LOH: Loss of heterozygosity; EGFR: Epidermal growth factor receptor; PTEN: Phosphatase and tensin homolog.